title: Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression.
authors.forename: Sotirios G
authors.initials: SG
authors.lastname: Papageorgiou
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Pappa
authors.forename: Christina
authors.initials: C
authors.lastname: Economopoulou
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Tsirigotis
authors.forename: Frida
authors.initials: F
authors.lastname: Konsioti
authors.forename: Eleni-Dikaia
authors.initials: ED
authors.lastname: Ionnidou
authors.forename: Spyros
authors.initials: S
authors.lastname: Chondropoulos
authors.forename: Diamantina
authors.initials: D
authors.lastname: Vasilatou
authors.forename: Efstathios
authors.initials: E
authors.lastname: Papageorgiou
authors.forename: Theofanis
authors.initials: T
authors.lastname: Economopoulos
authors.forename: John
authors.initials: J
authors.lastname: Dervenoulas
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D016543:Central Nervous System Neoplasms / Q000556:secondary*; D000069439:Dasatinib; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D007621:Karyotyping; D007947:Leukemia, Megakaryoblastic, Acute / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D000069439:Dasatinib